Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model
ImmunoTargets and Therapy · 2026-06 · Volume 15 · 1-16
DOI: 10.2147/itt.s597338 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-06. Verfasst von Junpeng Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua Uni…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, People's Republic of China.
- Department of Hepatobiliary Intervention, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, People's Republic of China.
- Yttrium-90 Precision Interventional Radiotherapy Center, School of Clinical Medicine, Tsinghua Medicine, Tsinghua Changgung Hospital, Tsinghua University, Beijing, People's Republic of China.
- Navy Clinical College, the Fifth School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, People's Republic of China.
- Department of General Surgery, The Sixth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
- Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Zitieren
APA
Ma, J., Wang, M., Wang, K., Wen, J., Liu, X., & Zhao, X. (2026). Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model. ImmunoTargets and Therapy, Volume 15, 1-16. https://doi.org/10.2147/itt.s597338
Vancouver
Ma J, Wang M, Wang K, Wen J, Liu X, Zhao X. Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model. ImmunoTargets and Therapy. 2026;Volume 15:1-16. doi:10.2147/itt.s597338
BibTeX
@article{Ma2026,
author = {Ma, Junpeng and Wang, Mingkun and Wang, Kunnan and Wen, Juyi and Liu, Xiaoya and Zhao, Xiangfei},
title = {Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model},
journal = {ImmunoTargets and Therapy},
year = {2026},
volume = {Volume 15},
pages = {1--16},
doi = {10.2147/itt.s597338}
}
EUVIMED